SeaSpine commercially launched OsteoStrand Demineralized Bone Fibers, with the first implantations occurring in Connecticut and California.
Here are five things to know:
1. The OsteoStrand builds on SeaSpine's demineralized bone matrix family with products designed to facilitate and enhance fusion. OsteoStrand fibers provide 100 percent demineralized bone fibers to maximize osteoinductivity.
2. Khalid Abbed, MD, vice chair of neurosurgery and director of minimally invasive spine surgery at Yale School of Medicine in New Haven, Conn., and Michael Cluck, MD, PhD, of Bay Area Spine Care in San Jose, Calif., performed the first procedures with OsteoStrand.
"The handling properties of OsteoStrand Demineralized Bone Fibers are excellent; it is easily compressible and expands to fill the surgical defect upon implantation," said Dr. Cluck.
3. OsteoStrand is designed to maintain the surgical placement and position as well as allow the fibers to fill the surgical defect while improving fusion. "I believe this tissue product could lead to significant cost savings for my hospital and I look forward to evaluating OsteoStrand Plus with Accell Bone Matrix," said Dr. Abbed.
4. SeaSpine plans to launch OsteoStrand Plus Demineralized Bone Fibers with the Accell Bone Matrix in early 2018 on a limited basis. "We believe these product offerings deliver clinical value as payers and hospitals seek more cost-effective orthobiologic solutions," said Keith Valentine, CEO and president of SeaSpine.